European Pharmaceutical Review brings you the latest information on every area of drug analysis, formulation, delivery, manufacturing, and regulatory affairs. With a 20-year track record of delivering in-depth reports and analysis, it offers insights into new and emerging technologies and contributions from respected members of the life sciences community. European Pharmaceutical Review is distributed regularly to top managers and decision-makers in the pharmaceutical, life sciences, and drug discovery sectors, mainly in Europe and also in the US.
As demand for safety-syringes rises, so does the market for pre-filled safety-engineered devices. This article explores the main reasons behind this growth—often due to aging populations with long-term conditions like diabetes, rheumatoid arthritis, or psoriasis, which typically need regular subcutaneous injections. One important strategy for addressing these challenges is supporting self-administration of medications. There’s also a shift to carers taking a bigger role, with more injections given at home or with the support of visiting nurses.